<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font7" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font9" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font11" size="6" family="GillSans" color="#000000"/>
	<fontspec id="font12" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font13" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font14" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font16" size="7" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="14" family="TTA202F0E8t00" color="#000000"/>
	<fontspec id="font18" size="16" family="TTA202F0E8t00" color="#000000"/>
	<fontspec id="font19" size="16" family="TTA2032AC8t00" color="#000000"/>
	<fontspec id="font20" size="16" family="TTA2032AC8t00" color="#000000"/>
	<fontspec id="font21" size="12" family="TTA2032AC8t00" color="#000000"/>
<text top="41" left="55" width="126" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">BMC Pharmacology 2006, 6 :13<i>BMC Pharmacology</i></text>
<text top="41" left="368" width="186" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.biomedcentral.com/1471-2210/6/13</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="94" segment_no="12" tag_type="text">Page 3 of 9<b>6</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="95" segment_no="13" tag_type="text">(page number not for citation purposes)</text>
<text top="251" left="55" width="100" height="9" font="font4" id="p1_t5" reading_order_no="41" segment_no="5" tag_type="title">PKC subtype expression</text>
<text top="263" left="55" width="241" height="9" font="font5" id="p1_t6" reading_order_no="42" segment_no="7" tag_type="text">Western blot experiments were carried out using antibod-</text>
<text top="275" left="55" width="241" height="9" font="font5" id="p1_t7" reading_order_no="43" segment_no="7" tag_type="text">ies directed specifically against phosphorylated, and<i>(page number not for citation purposes)</i></text>
<text top="284" left="55" width="241" height="13" font="font5" id="p1_t8" reading_order_no="44" segment_no="7" tag_type="text">thereby activated, PKC isoforms ( α , β I, γ , δ and ε ). These<i><b>PKC subtype expression</b></i></text>
<text top="298" left="55" width="241" height="9" font="font5" id="p1_t9" reading_order_no="45" segment_no="7" tag_type="text">tests showed that PKCi 20–28 was able to decrease the</text>
<text top="310" left="55" width="241" height="9" font="font5" id="p1_t10" reading_order_no="46" segment_no="7" tag_type="text">protein amount of all five PKC subtypes tested, although</text>
<text top="319" left="55" width="241" height="13" font="font5" id="p1_t11" reading_order_no="47" segment_no="7" tag_type="text">the decrease was most prominent for PKC δ (38% ± 20%</text>
<text top="331" left="55" width="241" height="13" font="font5" id="p1_t12" reading_order_no="48" segment_no="7" tag_type="text">of control, Fig. 4A) and PKC γ (51% ± 36% of control, Fig.</text>
<text top="345" left="55" width="241" height="9" font="font5" id="p1_t13" reading_order_no="49" segment_no="7" tag_type="text">4B). Conversely Ro-32-0432 and Bis I did not decrease the</text>
<text top="357" left="55" width="146" height="9" font="font5" id="p1_t14" reading_order_no="50" segment_no="7" tag_type="text">protein levels of the PKC subtypes.</text>
<text top="251" left="313" width="52" height="10" font="font7" id="p1_t15" reading_order_no="51" segment_no="6" tag_type="title">Discussion</text>
<text top="263" left="313" width="241" height="9" font="font5" id="p1_t16" reading_order_no="52" segment_no="8" tag_type="text">This study shows that each of the three general PKC inhib-</text>
<text top="275" left="313" width="241" height="9" font="font5" id="p1_t17" reading_order_no="53" segment_no="8" tag_type="text">itors attenuates the organ culture induced upregulation of</text>
<text top="286" left="313" width="242" height="11" font="font5" id="p1_t18" reading_order_no="54" segment_no="8" tag_type="text">the ET B receptor mediated contraction seen in rat MCA. A</text>
<text top="298" left="313" width="241" height="9" font="font5" id="p1_t19" reading_order_no="55" segment_no="8" tag_type="text">fourth PKC inhibitor, chelerythrine chloride, had no</text>
<text top="310" left="313" width="241" height="9" font="font5" id="p1_t20" reading_order_no="56" segment_no="8" tag_type="text">effect on the contractile responses of the arteries, and con-</text>
<text top="322" left="313" width="241" height="9" font="font5" id="p1_t21" reading_order_no="57" segment_no="8" tag_type="text">sequently was not included in the additional experiments.</text>
<text top="333" left="313" width="241" height="9" font="font5" id="p1_t22" reading_order_no="58" segment_no="8" tag_type="text">A possible explanation to this lack of effect could be that</text>
<text top="345" left="313" width="241" height="9" font="font5" id="p1_t23" reading_order_no="59" segment_no="8" tag_type="text">chelerythrine chloride has been shown to alter vasocon-</text>
<text top="357" left="313" width="241" height="9" font="font5" id="p1_t24" reading_order_no="60" segment_no="8" tag_type="text">strictive responses through interaction with various phos-</text>
<text top="87" left="55" width="373" height="7" font="font9" id="p1_t25" reading_order_no="2" segment_no="2" tag_type="title">Table 1: Contractile responses to S6c and ET-1 in MCA incubated with four different PKC inhibitors</text>
<text top="105" left="237" width="14" height="7" font="font9" id="p1_t26" reading_order_no="3" segment_no="3" tag_type="table">S6c</text>
<text top="105" left="408" width="18" height="7" font="font9" id="p1_t27" reading_order_no="4" segment_no="3" tag_type="table">ET-1<a href="">4A) and PKC</a></text>
<text top="115" left="207" width="4" height="7" font="font10" id="p1_t28" reading_order_no="5" segment_no="3" tag_type="table">n</text>
<text top="115" left="237" width="31" height="7" font="font10" id="p1_t29" reading_order_no="6" segment_no="3" tag_type="table">Emax (%)</text>
<text top="115" left="309" width="20" height="9" font="font10" id="p1_t30" reading_order_no="7" segment_no="3" tag_type="table">pEC 50<a href="">4B). Con</a>versely Ro-32-0432 and Bis I did not decrease the</text>
<text top="115" left="408" width="31" height="7" font="font10" id="p1_t31" reading_order_no="8" segment_no="3" tag_type="table">Emax (%)</text>
<text top="115" left="478" width="20" height="9" font="font10" id="p1_t32" reading_order_no="9" segment_no="3" tag_type="table">pEC 50<b>Discussion</b></text>
<text top="137" left="59" width="27" height="7" font="font10" id="p1_t33" reading_order_no="10" segment_no="3" tag_type="table">Control</text>
<text top="137" left="207" width="8" height="7" font="font10" id="p1_t34" reading_order_no="11" segment_no="3" tag_type="table">10</text>
<text top="137" left="237" width="26" height="7" font="font10" id="p1_t35" reading_order_no="12" segment_no="3" tag_type="table">131 ± 7</text>
<text top="137" left="309" width="38" height="7" font="font10" id="p1_t36" reading_order_no="13" segment_no="3" tag_type="table">9.13 ± 0.10</text>
<text top="137" left="408" width="26" height="7" font="font10" id="p1_t37" reading_order_no="14" segment_no="3" tag_type="table">152 ± 6</text>
<text top="137" left="478" width="38" height="7" font="font10" id="p1_t38" reading_order_no="15" segment_no="3" tag_type="table">8.74 ± 0.12</text>
<text top="148" left="59" width="70" height="7" font="font10" id="p1_t39" reading_order_no="16" segment_no="3" tag_type="table">Bisindolylmaleimide I</text>
<text top="148" left="207" width="8" height="7" font="font10" id="p1_t40" reading_order_no="17" segment_no="3" tag_type="table">14</text>
<text top="148" left="237" width="29" height="7" font="font10" id="p1_t41" reading_order_no="18" segment_no="3" tag_type="table">73 ± 8**</text>
<text top="148" left="309" width="38" height="7" font="font10" id="p1_t42" reading_order_no="19" segment_no="3" tag_type="table">8.97 ± 0.08</text>
<text top="148" left="408" width="26" height="7" font="font10" id="p1_t43" reading_order_no="20" segment_no="3" tag_type="table">143 ± 6</text>
<text top="148" left="478" width="38" height="7" font="font10" id="p1_t44" reading_order_no="21" segment_no="3" tag_type="table">8.70 ± 0.08<b>Table 1: Contractile responses to S6c and ET-1 in MCA incubated with four different PKC inhibitors</b></text>
<text top="158" left="59" width="76" height="7" font="font10" id="p1_t45" reading_order_no="22" segment_no="3" tag_type="table">Chelerythrine chloride<b>S6c</b></text>
<text top="158" left="207" width="4" height="7" font="font10" id="p1_t46" reading_order_no="23" segment_no="3" tag_type="table">9<b>ET-1</b></text>
<text top="158" left="237" width="26" height="7" font="font10" id="p1_t47" reading_order_no="24" segment_no="3" tag_type="table">102 ± 7</text>
<text top="158" left="309" width="38" height="7" font="font10" id="p1_t48" reading_order_no="25" segment_no="3" tag_type="table">8.95 ± 0.20</text>
<text top="158" left="408" width="26" height="7" font="font10" id="p1_t49" reading_order_no="26" segment_no="3" tag_type="table">139 ± 6</text>
<text top="158" left="478" width="38" height="7" font="font10" id="p1_t50" reading_order_no="27" segment_no="3" tag_type="table">8.77 ± 0.18</text>
<text top="168" left="59" width="69" height="7" font="font10" id="p1_t51" reading_order_no="28" segment_no="3" tag_type="table">PKC inhibitor 20–28</text>
<text top="168" left="207" width="8" height="7" font="font10" id="p1_t52" reading_order_no="29" segment_no="3" tag_type="table">14</text>
<text top="168" left="237" width="33" height="7" font="font10" id="p1_t53" reading_order_no="30" segment_no="3" tag_type="table">67 ± 10**</text>
<text top="168" left="309" width="38" height="7" font="font10" id="p1_t54" reading_order_no="31" segment_no="3" tag_type="table">8.80 ± 0.16</text>
<text top="168" left="408" width="26" height="7" font="font10" id="p1_t55" reading_order_no="32" segment_no="3" tag_type="table">145 ± 7</text>
<text top="168" left="478" width="38" height="7" font="font10" id="p1_t56" reading_order_no="33" segment_no="3" tag_type="table">8.64 ± 0.17</text>
<text top="178" left="59" width="40" height="7" font="font10" id="p1_t57" reading_order_no="34" segment_no="3" tag_type="table">Ro-32-0432</text>
<text top="178" left="207" width="4" height="7" font="font10" id="p1_t58" reading_order_no="35" segment_no="3" tag_type="table">9</text>
<text top="178" left="237" width="28" height="7" font="font10" id="p1_t59" reading_order_no="36" segment_no="3" tag_type="table">6 ± 3***</text>
<text top="178" left="309" width="48" height="7" font="font10" id="p1_t60" reading_order_no="37" segment_no="3" tag_type="table">8.92 ± 0.07***</text>
<text top="178" left="408" width="30" height="7" font="font10" id="p1_t61" reading_order_no="38" segment_no="3" tag_type="table">194 ± 12</text>
<text top="178" left="478" width="38" height="7" font="font10" id="p1_t62" reading_order_no="39" segment_no="3" tag_type="table">8.36 ± 0.09</text>
<text top="201" left="59" width="343" height="7" font="font10" id="p1_t63" reading_order_no="40" segment_no="4" tag_type="text">*P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001 compared to control. n represents the number of artery segments.</text>
<text top="677" left="55" width="135" height="9" font="font13" id="p1_t64" reading_order_no="90" segment_no="10" tag_type="title">Contractile response towards S6c</text>
<text top="677" left="55" width="37" height="9" font="font14" id="p1_t65" reading_order_no="89" segment_no="10" tag_type="title">Figure 1</text>
<text top="688" left="55" width="499" height="10" font="font14" id="p1_t66" reading_order_no="91" segment_no="11" tag_type="text">Contractile response towards S6c . Contractile responses towards the ET B receptor agonist S6c in MCAs incubated for 24</text>
<text top="699" left="55" width="499" height="9" font="font15" id="p1_t67" reading_order_no="92" segment_no="11" tag_type="text">hours (control) and MCAs incubated for 24 hours with PKC inhibitors (Bis I, Ro-32-0432, PKCi 20–28). Each point represents</text>
<text top="709" left="55" width="218" height="9" font="font15" id="p1_t68" reading_order_no="93" segment_no="11" tag_type="text">mean value ± S.E.M. For statistical analysis, see Table 1.</text>
<text top="612" left="120" width="20" height="18" font="font17" id="p1_t69" reading_order_no="77" segment_no="9" tag_type="figure">-12</text>
<text top="612" left="169" width="20" height="18" font="font17" id="p1_t70" reading_order_no="78" segment_no="9" tag_type="figure">-11</text>
<text top="612" left="218" width="20" height="18" font="font17" id="p1_t71" reading_order_no="79" segment_no="9" tag_type="figure">-10</text>
<text top="612" left="270" width="12" height="18" font="font17" id="p1_t72" reading_order_no="80" segment_no="9" tag_type="figure">-9</text>
<text top="612" left="319" width="12" height="18" font="font17" id="p1_t73" reading_order_no="81" segment_no="9" tag_type="figure">-8</text>
<text top="612" left="368" width="12" height="18" font="font17" id="p1_t74" reading_order_no="82" segment_no="9" tag_type="figure">-7</text>
<text top="612" left="417" width="12" height="18" font="font17" id="p1_t75" reading_order_no="83" segment_no="9" tag_type="figure">-6</text>
<text top="597" left="115" width="8" height="18" font="font17" id="p1_t76" reading_order_no="76" segment_no="9" tag_type="figure">0</text>
<text top="532" left="107" width="15" height="18" font="font17" id="p1_t77" reading_order_no="75" segment_no="9" tag_type="figure">50</text>
<text top="467" left="99" width="23" height="18" font="font17" id="p1_t78" reading_order_no="74" segment_no="9" tag_type="figure">100</text>
<text top="401" left="99" width="23" height="18" font="font17" id="p1_t79" reading_order_no="73" segment_no="9" tag_type="figure">150</text>
<text top="414" left="449" width="52" height="21" font="font18" id="p1_t80" reading_order_no="84" segment_no="9" tag_type="figure">Control</text>
<text top="464" left="449" width="83" height="21" font="font18" id="p1_t81" reading_order_no="86" segment_no="9" tag_type="figure">PKCi 20-28</text>
<text top="439" left="449" width="32" height="21" font="font18" id="p1_t82" reading_order_no="85" segment_no="9" tag_type="figure">Bis I</text>
<text top="490" left="449" width="84" height="21" font="font18" id="p1_t83" reading_order_no="87" segment_no="9" tag_type="figure">Ro-32-0432</text>
<text top="635" left="233" width="86" height="19" font="font19" id="p1_t84" reading_order_no="88" segment_no="9" tag_type="figure">S6c (log M)</text>
<text top="568" left="90" width="0" height="19" font="font20" id="p1_t85" reading_order_no="72" segment_no="9" tag_type="figure">C<i>n </i></text>
<text top="556" left="90" width="0" height="19" font="font20" id="p1_t86" reading_order_no="71" segment_no="9" tag_type="figure">o</text>
<text top="546" left="90" width="0" height="19" font="font20" id="p1_t87" reading_order_no="70" segment_no="9" tag_type="figure">n</text>
<text top="537" left="90" width="0" height="19" font="font20" id="p1_t88" reading_order_no="69" segment_no="9" tag_type="figure">tr<b>Figure 1</b></text>
<text top="524" left="90" width="0" height="19" font="font20" id="p1_t89" reading_order_no="68" segment_no="9" tag_type="figure">ac<b>Contractile response towards S6c</b></text>
<text top="506" left="90" width="0" height="19" font="font20" id="p1_t90" reading_order_no="67" segment_no="9" tag_type="figure">ti</text>
<text top="496" left="90" width="0" height="19" font="font20" id="p1_t91" reading_order_no="66" segment_no="9" tag_type="figure">on (</text>
<text top="466" left="90" width="0" height="19" font="font20" id="p1_t92" reading_order_no="65" segment_no="9" tag_type="figure">%</text>
<text top="451" left="90" width="0" height="19" font="font20" id="p1_t93" reading_order_no="64" segment_no="9" tag_type="figure">of</text>
<text top="431" left="90" width="0" height="19" font="font20" id="p1_t94" reading_order_no="63" segment_no="9" tag_type="figure">K</text>
<text top="418" left="80" width="0" height="14" font="font21" id="p1_t95" reading_order_no="62" segment_no="9" tag_type="figure">+</text>
<text top="406" left="90" width="0" height="19" font="font20" id="p1_t96" reading_order_no="61" segment_no="9" tag_type="figure">)</text>
</page>
</pdf2xml>
